NANOVIRICIDES, INC.
For the period ended Jun 30, 2026. Filed Sep 28, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: September 28, 2026
| NANOVIRICIDES, INC. | |
| /s/ Anil Diwan, PhD | |
| Name: | Anil Diwan, PhD. |
| Title: | President and Executive Chairman of the Board of Directors |
| (Principal Executive Officer) | |
| /s/ Meeta Vyas | |
| Name: | Meeta Vyas |
| Title: | Chief Financial Officer |
| (Principal Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| September 28, 2026 | /s/ Anil Diwan, PhD | |
|---|---|---|
| Name: | Anil Diwan, PhD | |
| Title: | President and Executive Chairman of the Board of Directors | |
| (Principal Executive Officer) |
| September 28, 2026 | /s/ Meeta Vyas | |
|---|---|---|
| Name: | Meeta Vyas | |
| Title: | Chief Financial Officer | |
| (Principal Accounting Officer) |
| September 28, 2026 | /s/ Brian Zucker | |
|---|---|---|
| Name: | Brian Zucker | |
| Title: | Director |
| September 28, 2026 | /s/ Makarand Jawadekar | |
|---|---|---|
| Name: | Makarand Jawadekar | |
| Title: | Director |
| September 28, 2026 | /s/ Theodore Rokita | |
|---|---|---|
| Name: | Theodore Rokita | |
| Title: | Director |
Index to the Financial Statements
| Contents | | Page(s) |
|---|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 274) | F-2 – F-3 | |
| Balance Sheets at June 30, 2026 and 2025 | F-4 | |
| Statements of Operations for the years ended June 30, 2026 and 2025 | F-5 | |
| Statement of Changes in Stockholders’ Equity for the years ended June 30, 2026 and 2025 | F-6 | |
| Statements of Cash Flows for the years ended June 30, 2026 and 2025 | F-7 | |
| Notes to the Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.